TGFB1 and neoplasm: This allowed us to determine that the effect was correlated with an increase in T-cell penetration into the tumor (Figure 4C, D) as demonstrated for colorectal and urothelial metastatic cancers in the liver when inhibiting TGFβ using the small molecule, galunisertib (6,10).